The biopharmaceutical contract manufacturing market is projected to grow at a CAGR of 10%

With the advent of novel technologies and rising preference for such therapeutic interventions, biologics have made a significant impact in the pharmaceutical domain, delivering a ground-breaking treatment regimen for a myriad of disease indications.